AMRX ▼ -1.2% - Amneal Pharmaceuticals, Inc.
$AMRX reported Q3 2026 Adj EPS of $0.26, beating the $0.24 estimate by 8.3%. Revenue of $862.7M beat the $817.9M estimate by 5.5%.
03-NOV-2026 06:09 AM ET
Share this post
More filings for $AMRX
AMRX ▼ -1.2% - Amneal Pharmaceuticals, Inc.Nov 3, 2026AMRX ▲ +2.0% - Amneal Pharmaceuticals, Inc.Sep 18, 2026AMRX - Amneal Pharmaceuticals, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026AMRX - Amneal Pharmaceuticals, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026AMRX - Amneal Pharmaceuticals, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026
View full $AMRX filing history →💬 Comments
Loading comments…
Leave a comment